• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity.髓源性抑制细胞是黑色素瘤微环境中 Wnt5A 的主要来源,并且依赖于 Wnt5A 发挥完全抑制活性。
Cancer Res. 2021 Feb 1;81(3):658-670. doi: 10.1158/0008-5472.CAN-20-1238. Epub 2020 Dec 1.
2
Prophylactic DNA vaccine targeting Foxp3 regulatory T cells depletes myeloid-derived suppressor cells and improves anti-melanoma immune responses in a murine model.针对 Foxp3 调节性 T 细胞的预防性 DNA 疫苗可耗竭髓系来源的抑制细胞,改善小鼠模型中的抗黑色素瘤免疫反应。
Cancer Immunol Immunother. 2018 Mar;67(3):367-379. doi: 10.1007/s00262-017-2088-6. Epub 2017 Nov 9.
3
TAM Family Receptor Kinase Inhibition Reverses MDSC-Mediated Suppression and Augments Anti-PD-1 Therapy in Melanoma.TAM 家族受体激酶抑制逆转 MDSC 介导的抑制作用,并增强黑色素瘤的抗 PD-1 治疗。
Cancer Immunol Res. 2019 Oct;7(10):1672-1686. doi: 10.1158/2326-6066.CIR-19-0008. Epub 2019 Aug 26.
4
Nanoparticle-Mediated Trapping of Wnt Family Member 5A in Tumor Microenvironments Enhances Immunotherapy for B-Raf Proto-Oncogene Mutant Melanoma.纳米颗粒介导的 Wnt 家族成员 5A 在肿瘤微环境中的捕获增强了 B-Raf 原癌基因突变型黑色素瘤的免疫治疗。
ACS Nano. 2018 Feb 27;12(2):1250-1261. doi: 10.1021/acsnano.7b07384. Epub 2018 Jan 31.
5
Tumor-derived GLI1 promotes remodeling of the immune tumor microenvironment in melanoma.肿瘤源性 GLI1 促进黑色素瘤中免疫肿瘤微环境的重塑。
J Exp Clin Cancer Res. 2024 Aug 2;43(1):214. doi: 10.1186/s13046-024-03138-0.
6
Immunosuppressive activity is attenuated by Astragalus polysaccharides through remodeling the gut microenvironment in melanoma mice.黄芪多糖通过重塑黑色素瘤小鼠的肠道微环境来减弱免疫抑制活性。
Cancer Sci. 2021 Oct;112(10):4050-4063. doi: 10.1111/cas.15078. Epub 2021 Aug 3.
7
Visualization and quantification of homing kinetics of myeloid-derived suppressor cells in primary and metastatic cancer.可视化和量化髓源性抑制细胞在原发性和转移性癌症中的归巢动力学。
Theranostics. 2019 Aug 12;9(20):5869-5885. doi: 10.7150/thno.33275. eCollection 2019.
8
Semaphorin4D Inhibition Improves Response to Immune-Checkpoint Blockade via Attenuation of MDSC Recruitment and Function.Semaphorin4D 抑制通过减弱 MDSC 募集和功能改善免疫检查点阻断的反应。
Cancer Immunol Res. 2019 Feb;7(2):282-291. doi: 10.1158/2326-6066.CIR-18-0156. Epub 2018 Dec 4.
9
IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma.IL-6 调节小鼠黑色素瘤中 MDSC 的 CCR5 表达和免疫抑制能力。
J Immunother Cancer. 2020 Aug;8(2). doi: 10.1136/jitc-2020-000949.
10
Arginase-1 is neither constitutively expressed in nor required for myeloid-derived suppressor cell-mediated inhibition of T-cell proliferation.精氨酸酶 1 既不在髓系来源的抑制性细胞中组成性表达,也不是其介导 T 细胞增殖抑制所必需的。
Eur J Immunol. 2018 Jun;48(6):1046-1058. doi: 10.1002/eji.201747355. Epub 2018 Mar 23.

引用本文的文献

1
CDKN2A and matrix metalloproteinases: key regulators of cellular senescence in squamous cell carcinoma.CDKN2A与基质金属蛋白酶:鳞状细胞癌中细胞衰老的关键调节因子
Am J Transl Res. 2025 Jun 15;17(6):4573-4589. doi: 10.62347/FKDS7259. eCollection 2025.
2
Wnt signaling pathways in biology and disease: mechanisms and therapeutic advances.生物学与疾病中的Wnt信号通路:机制与治疗进展
Signal Transduct Target Ther. 2025 Apr 4;10(1):106. doi: 10.1038/s41392-025-02142-w.
3
EIF2S2 as a prognostic marker and therapeutic target in glioblastoma: insights into its role and downstream mechanisms.EIF2S2作为胶质母细胞瘤的预后标志物和治疗靶点:对其作用及下游机制的见解
Cancer Cell Int. 2025 Apr 2;25(1):126. doi: 10.1186/s12935-025-03762-6.
4
WNT5A in Cancer: A Pan-Cancer Analysis Revealing Its Diagnostic and Prognostic Biomarker Potential.癌症中的WNT5A:一项泛癌分析揭示其作为诊断和预后生物标志物的潜力
Cureus. 2024 Jul 23;16(7):e65190. doi: 10.7759/cureus.65190. eCollection 2024 Jul.
5
Innate Immune Cells in Melanoma: Implications for Immunotherapy.固有免疫细胞在黑色素瘤中的作用:免疫治疗的启示。
Int J Mol Sci. 2024 Aug 5;25(15):8523. doi: 10.3390/ijms25158523.
6
Immune Regulation and Immune Therapy in Melanoma: Review with Emphasis on CD155 Signalling.黑色素瘤中的免疫调节与免疫治疗:重点关注CD155信号传导的综述
Cancers (Basel). 2024 May 21;16(11):1950. doi: 10.3390/cancers16111950.
7
Secretome of Cancer-Associated Fibroblasts (CAFs) Influences Drug Sensitivity in Cancer Cells.肿瘤相关成纤维细胞(CAFs)的外泌体影响癌细胞对药物的敏感性。
J Proteome Res. 2024 Jun 7;23(6):2160-2168. doi: 10.1021/acs.jproteome.4c00112. Epub 2024 May 20.
8
Key players of immunosuppression in epithelial malignancies: Tumor-infiltrating myeloid cells and γδ T cells.上皮性恶性肿瘤中免疫抑制的关键因素:肿瘤浸润髓系细胞和 γδ T 细胞。
Cancer Rep (Hoboken). 2024 May;7(5):e2066. doi: 10.1002/cnr2.2066.
9
Immune escape and metastasis mechanisms in melanoma: breaking down the dichotomy.黑色素瘤中的免疫逃逸和转移机制:打破二分法。
Front Immunol. 2024 Feb 14;15:1336023. doi: 10.3389/fimmu.2024.1336023. eCollection 2024.
10
Myeloid-derived suppressor cells in cancer and cancer therapy.髓源性抑制细胞在癌症和癌症治疗中的作用。
Nat Rev Clin Oncol. 2024 Feb;21(2):147-164. doi: 10.1038/s41571-023-00846-y. Epub 2024 Jan 8.

本文引用的文献

1
Paradoxical Role for Wild-Type p53 in Driving Therapy Resistance in Melanoma.野生型 p53 在驱动黑色素瘤治疗抵抗中的矛盾作用。
Mol Cell. 2020 Feb 6;77(3):633-644.e5. doi: 10.1016/j.molcel.2019.11.009. Epub 2019 Dec 11.
2
Wnt5a is a TLR2/4-ligand that induces tolerance in human myeloid cells.Wnt5a 是一种 TLR2/4 配体,可诱导人髓样细胞产生耐受。
Commun Biol. 2019 May 9;2:176. doi: 10.1038/s42003-019-0432-4. eCollection 2019.
3
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy.转化生长因子-β1 编程的髓源性抑制细胞(MDSC)获得了免疫刺激和肿瘤杀伤活性,能够与放疗联合抑制已形成的肿瘤。
Oncoimmunology. 2018 Jul 26;7(10):e1490853. doi: 10.1080/2162402X.2018.1490853. eCollection 2018.
4
Age Correlates with Response to Anti-PD1, Reflecting Age-Related Differences in Intratumoral Effector and Regulatory T-Cell Populations.年龄与抗 PD-1 反应相关,反映了肿瘤内效应和调节性 T 细胞群体的年龄相关差异。
Clin Cancer Res. 2018 Nov 1;24(21):5347-5356. doi: 10.1158/1078-0432.CCR-18-1116. Epub 2018 Jun 13.
5
BRN2, a POUerful driver of melanoma phenotype switching and metastasis.BRN2,黑色素瘤表型转换和转移的强大驱动因素。
Pigment Cell Melanoma Res. 2019 Jan;32(1):9-24. doi: 10.1111/pcmr.12710. Epub 2018 Jun 5.
6
Targeting Myeloid-Derived Suppressor Cells to Bypass Tumor-Induced Immunosuppression.靶向髓系来源抑制细胞以绕过肿瘤诱导的免疫抑制。
Front Immunol. 2018 Mar 2;9:398. doi: 10.3389/fimmu.2018.00398. eCollection 2018.
7
CXCR2 MDSCs promote breast cancer progression by inducing EMT and activated T cell exhaustion.CXCR2 髓系来源的抑制细胞通过诱导上皮-间质转化和激活的 T 细胞耗竭促进乳腺癌进展。
Oncotarget. 2017 Dec 7;8(70):114554-114567. doi: 10.18632/oncotarget.23020. eCollection 2017 Dec 29.
8
Interleukin-6 -Signaling Pathway Promotes Immunosuppressive Myeloid-Derived Suppressor Cells Suppression of Suppressor of Cytokine Signaling 3 in Breast Cancer.白细胞介素-6信号通路促进免疫抑制性髓源性抑制细胞对乳腺癌中细胞因子信号转导抑制因子3的抑制作用。
Front Immunol. 2017 Dec 15;8:1840. doi: 10.3389/fimmu.2017.01840. eCollection 2017.
9
Treg depletion potentiates checkpoint inhibition in claudin-low breast cancer.调节性T细胞耗竭增强了Claudin低表达型乳腺癌中的检查点抑制作用。
J Clin Invest. 2017 Sep 1;127(9):3472-3483. doi: 10.1172/JCI90499. Epub 2017 Aug 21.
10
CXCL1 Is Critical for Premetastatic Niche Formation and Metastasis in Colorectal Cancer.CXCL1对结直肠癌前转移微环境的形成和转移至关重要。
Cancer Res. 2017 Jul 1;77(13):3655-3665. doi: 10.1158/0008-5472.CAN-16-3199. Epub 2017 Apr 28.

髓源性抑制细胞是黑色素瘤微环境中 Wnt5A 的主要来源,并且依赖于 Wnt5A 发挥完全抑制活性。

Myeloid-Derived Suppressor Cells Are a Major Source of Wnt5A in the Melanoma Microenvironment and Depend on Wnt5A for Full Suppressive Activity.

机构信息

Department of Biochemistry and Molecular Biology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.

Department of Oncology, Sidney Kimmel Cancer Center, Johns Hopkins School of Medicine, Baltimore, Maryland.

出版信息

Cancer Res. 2021 Feb 1;81(3):658-670. doi: 10.1158/0008-5472.CAN-20-1238. Epub 2020 Dec 1.

DOI:10.1158/0008-5472.CAN-20-1238
PMID:33262126
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8330365/
Abstract

Metastatic dissemination remains a significant barrier to successful therapy for melanoma. Wnt5A is a potent driver of invasion in melanoma and is believed to be secreted from the tumor microenvironment (TME). Our data suggest that myeloid-derived suppressor cells (MDSC) in the TME are a major source of Wnt5A and are reliant upon Wnt5A for multiple actions. Knockdown of Wnt5A specifically in the myeloid cells demonstrated a clear decrease in Wnt5A expression within the TME as well as a decrease in intratumoral MDSC and regulatory T cell (Treg). Wnt5A knockdown also decreased the immunosuppressive nature of MDSC and decreased expression of TGFβ1 and arginase 1. In the presence of Wnt5A-depleted MDSC, tumor-infiltrating lymphocytes expressed decreased PD-1 and LAG3, suggesting a less exhausted phenotype. Myeloid-specific Wnt5A knockdown also led to decreased lung metastasis. Tumor-infiltrating MDSC from control animals showed a strong positive correlation with Treg, which was completely ablated in animals with Wnt5A-negative MDSC. Overall, our data suggest that while MDSC contribute to an immunosuppressive and less immunogenic environment, they exhibit an additional function as the major source of Wnt5A in the TME. SIGNIFICANCE: These findings demonstrate that myeloid cells provide a major source of Wnt5A to facilitate metastatic potential in melanoma cells and rely on Wnt5A for their immunosuppressive function.

摘要

转移扩散仍然是黑色素瘤成功治疗的重大障碍。Wnt5A 是黑色素瘤侵袭的有力驱动因素,据信它是由肿瘤微环境(TME)分泌的。我们的数据表明,TME 中的髓系来源的抑制细胞(MDSC)是 Wnt5A 的主要来源,并且依赖于 Wnt5A 发挥多种作用。在髓系细胞中特异性敲低 Wnt5A 可明显降低 TME 中的 Wnt5A 表达,并减少肿瘤内 MDSC 和调节性 T 细胞(Treg)。Wnt5A 敲低还降低了 MDSC 的免疫抑制特性,并降低了 TGFβ1 和精氨酸酶 1 的表达。在缺乏 Wnt5A 的 MDSC 存在的情况下,肿瘤浸润淋巴细胞表达的 PD-1 和 LAG3 减少,表明表型衰竭程度降低。髓系特异性 Wnt5A 敲低也导致肺转移减少。来自对照动物的肿瘤浸润 MDSC 与 Treg 呈强烈正相关,而在缺乏 Wnt5A 的 MDSC 动物中,这种相关性完全消失。总体而言,我们的数据表明,虽然 MDSC 有助于形成免疫抑制和免疫原性较低的环境,但它们还表现出另一种功能,即作为 TME 中 Wnt5A 的主要来源。意义:这些发现表明,髓系细胞提供了 Wnt5A 的主要来源,以促进黑色素瘤细胞的转移潜力,并依赖 Wnt5A 发挥其免疫抑制功能。